Author(s): Madian AG, Wheeler HE, Jones RB, Dolan ME
Abstract Share this page
Abstract Although sequencing a single human genome was a monumental effort a decade ago, more than 1000 genomes have now been sequenced. The task ahead lies in transforming this information into personalized treatment strategies that are tailored to the unique genetics of each individual. One important aspect of personalized medicine is patient-to-patient variation in drug response. Pharmacogenomics addresses this issue by seeking to identify genetic contributors to human variation in drug efficacy and toxicity. Here, we present a summary of the current status of this field, which has evolved from studies of single candidate genes to comprehensive genome-wide analyses. Additionally, we discuss the major challenges in translating this knowledge into a systems-level understanding of drug physiology, with the ultimate goal of developing more effective personalized clinical treatment strategies. Copyright © 2012 Elsevier Ltd. All rights reserved.
This article was published in Trends Genet
and referenced in Advances in Pharmacoepidemiology and Drug Safety